LT-HSC (long term HSC) isolated from transgenic BCR-ABL+ mice and CML patients exhibited decreased bone marrow CXCL12 which debilitated their homing and engraftment in CML bone marrow. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.